Well-differentiated Pancreatic Neuroendocrine Tumor
1 clinical trials · Condition
◉ Watch Well-differentiated Pancreatic Neuroendocrine Tumor
| Record | Firm | Date |
|---|---|---|
| A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors (NCT01525550) | Pfizer | 2012-06-06 |
Track Well-differentiated Pancreatic Neuroendocrine Tumor automatically
Every clearance here is in the API, with alerts when new ones post.